Bone growth stimulators receive FDA and CE Mark approvals

9th March 2018
Enaie Azambuja

Orthofix International N.V., has announced the FDA and European CE Mark approvals for its next-generation PhysioStim bone growth stimulators. The PhysioStim devices provide a non-surgical treatment option for patients who have a nonunion fracture to an extremity that has shown no visible signs of healing. These Class III medical devices use a pulsed electromagnetic field (PEMF) signal to induce a low-level electrical field at the fracture site which stimulates bone healing.

"We are proud to provide physicians with these next-generation devices that will enable them to redefine how patients with nonunion fractures are treated," said Brad Niemann, President of the Orthofix BioStim strategic business unit.

"These devices are built on our proprietary PEMF technology platform. Together with our spinal fusion stimulators, they are currently the No. 1 prescribed bone growth stimulators in the U.S."

The PhysioStim devices will be accompanied by a new application for mobile devices, STIM onTrack. Designed for use with smartphones and other mobile devices, STIM onTrack is free and available in the U.S. through the iTunes App Store.

The STIM onTrack mobile app includes a first-to-market feature that enables physicians to remotely view patient adherence to their prescription. Additionally, the app engages patients in their recovery process through treatment calendars, therapy reminders and educational resources.

"Bone growth stimulation therapy is a safe, effective and proven treatment for patients who have a fracture to an extremity that won't heal," said James Ryaby, Ph.D., Chief Scientific Officer at Orthofix.

"When patients follow their prescription, their rate of successful healing is improved. The new mobile app is a great tool to foster better adherence to the prescribed treatment because it empowers the patient to take an active part in their recovery."

The PhysioStim devices come in different models and are designed to anatomically fit the patient's body. Specific applications are for treatment of nonunion fractures to the arm, hand, wrist, clavicle, shoulder, hip, thigh, lower leg, ankle or foot.

The devices can be worn over clothing, casts or internal and external surgical fixation devices. Orthofix invites those attending the AAOS Annual Meeting to visit Booth #2351, Hall D to learn more about our next-generation bone growth stimulation devices.

A leader in the bone growth stimulation market, Orthofix is dedicated to expanding indications for the use of PEMF devices. The Company is currently conducting three investigational device exemption (IDE) clinical trials to collect safety and effectiveness data of the Physio-Stim system for osteoarthritis of the knee, the RCStim system as an adjunctive treatment to surgical repair of full thickness rotator cuff tears and the Cervical-Stim system for treating odontoid fractures.

Featured products

Product Spotlight

Upcoming Events

View all events
Latest global electronics news
© Copyright 2021 Electronic Specifier